It was strange that OncXerna closed the doors when I was questioning with the SEC why Oncxerna seemed to be slow walking Bavi with exclusively never ending phase 2 trials. Rolf indicated he was out of the loop but also found it strange that Bavi was still in phase 2 trials. And yes it was phase 3 trials that revenues would begin to be paid out to Avid. In my opinion this was all very strange.
Now it could be OncXerna just couldn't finance a phase 3 trial with royalties being paid out. But with the low ball buyout I just have to wonder.
Market Data 
Markets 
AI
